Virtus ETF Advisers’s CareDx CDNA Stock Holding History

Virtus ETF Advisers’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	42,046 +1,482	+4%	+$32.3K	0.46%	44
2026 Q1	$704K	Hold	40,564	–	–	0.33%	74
2025 Q4	$764K	Hold	40,564	–	–	0.36%	63
2025 Q3	$590K	Hold	40,564	–	–	0.32%	84
2025 Q2	$793K	Hold	40,564	–	–	0.48%	56
2025 Q1	$720K	Buy	+40,564	New	+$874K	0.47%	52

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus ETF Advisers's CDNA Position: Q2 2026 in Review

Virtus ETF Advisers increased its CareDx (CDNA) stake by 3.7% in Q2 2026, buying an estimated $32.3K and bringing the position to 42,046 shares worth $1.2M. The position accounts for 0.46% of the portfolio, ranked #44.

Virtus ETF Advisers first reported a position in CDNA in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Virtus ETF Advisers held 42,046 shares of CareDx worth $1.2M as of Q2 2026.
Virtus ETF Advisers bought 1,482 CareDx shares in Q2 2026, an estimated $32.3K.
CareDx made up 0.46% of Virtus ETF Advisers's portfolio in Q2 2026, its #44 holding.
Virtus ETF Advisers first reported a position in CareDx in Q1 2025 and has held it in 6 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.